Day J, Hamann P
Diagnostics (Basel). 2025; 14(24.
PMID: 39767202
PMC: 11675675.
DOI: 10.3390/diagnostics14242842.
Roumi J, Taimeh Z
Curr Heart Fail Rep. 2024; 21(6):570-579.
PMID: 39365404
PMC: 11511729.
DOI: 10.1007/s11897-024-00683-9.
Casanova N, Camp S, Gonzalez-Garay M, Batai K, Garman L, Montgomery C
Eur J Respir Med. 2024; 5(1):359-371.
PMID: 38390497
PMC: 10883688.
Ji H, Xi N, Mohan C, Yan X, Jain K, Zang Q
Front Immunol. 2024; 14:1342429.
PMID: 38250062
PMC: 10797773.
DOI: 10.3389/fimmu.2023.1342429.
Drake W, Hsia C, Samavati L, Yu M, Cardenas J, Gianella F
BMJ Open. 2023; 13(4):e071607.
PMID: 37012011
PMC: 10083794.
DOI: 10.1136/bmjopen-2023-071607.
Routine Laboratory Biomarkers As Prognostic Indicators of Cardiac Sarcoidosis Outcomes.
Kolluri N, Schmidt T, Elwazir M, Kapa S, Abou Ezzeddine O, Bois J
Sarcoidosis Vasc Diffuse Lung Dis. 2023; 39(3):e2022023.
PMID: 36791034
PMC: 9766851.
DOI: 10.36141/svdld.v39i2.11136.
Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis.
Kobayashi Y, Sato T, Nagai T, Hirata K, Tsuneta S, Kato Y
ESC Heart Fail. 2021; 8(6):5282-5292.
PMID: 34514715
PMC: 8712796.
DOI: 10.1002/ehf2.13614.
Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific granulomas.
Casanova N, Gonzalez-Garay M, Sun B, Bime C, Sun X, Knox K
Respir Res. 2020; 21(1):321.
PMID: 33276795
PMC: 7716494.
DOI: 10.1186/s12931-020-01537-3.
Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis.
Miyata J, Ogawa T, Tagami Y, Sato T, Nagayama M, Hirano T
Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(1):8-16.
PMID: 33093764
PMC: 7569541.
DOI: 10.36141/svdld.v37i1.8313.
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study.
Rahaghi F, Sweiss N, Saketkoo L, Scholand M, Barney J, Gerke A
Eur Respir Rev. 2020; 29(155).
PMID: 32198219
PMC: 9489143.
DOI: 10.1183/16000617.0147-2019.
Pediatric Sarcoidosis: A Review with Emphasis on Early Onset and High-Risk Sarcoidosis and Diagnostic Challenges.
Chiu B, Chan J, Das S, Alshamma Z, Sergi C
Diagnostics (Basel). 2019; 9(4).
PMID: 31731423
PMC: 6963233.
DOI: 10.3390/diagnostics9040160.
Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis.
Inaoka P, Shono M, Kamada M, Espinoza J
J Biomed Sci. 2019; 26(1):45.
PMID: 31182092
PMC: 6558716.
DOI: 10.1186/s12929-019-0537-6.
Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3.
Lee C, He C, Park J, Lee J, Kamle S, Ma B
Life Sci Alliance. 2019; 2(3).
PMID: 31085559
PMC: 6516052.
DOI: 10.26508/lsa.201900350.
Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis.
Kishore A, Petrek M
Front Genet. 2018; 9:503.
PMID: 30410504
PMC: 6210504.
DOI: 10.3389/fgene.2018.00503.
Biomarkers in Sarcoidosis: Can microRNAs Fill the Gap?.
Bonham C
Am J Respir Cell Mol Biol. 2017; 58(1):1-2.
PMID: 29286860
PMC: 5941313.
DOI: 10.1165/rcmb.2017-0344ED.
A Circulating MicroRNA Signature Serves as a Diagnostic and Prognostic Indicator in Sarcoidosis.
Ascoli C, Huang Y, Schott C, Turturice B, Metwally A, Perkins D
Am J Respir Cell Mol Biol. 2017; 58(1):40-54.
PMID: 28812922
PMC: 5941311.
DOI: 10.1165/rcmb.2017-0207OC.
Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosis.
Singla S, Zhou T, Javaid K, Abbasi T, Casanova N, Zhang W
Pulm Circ. 2017; 6(4):465-471.
PMID: 28090288
PMC: 5210052.
DOI: 10.1086/688316.